NEOG
NEOGEN CORP
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$11.63
−1.52%Margins
Gross margin
47.4%
EBITDA margin
11.9%
EBIT margin
-0.8%
Net margin
-6.3%
FCF margin
5.6%
-2.7%
Return on equity
-1.7%
Return on assets
-0.3%
Return on invested capital
0.27x
Asset turnover
$85.2M
Cash from operations
$0.79
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Aug 1, 2026